NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.5000
-0.0100 (-1.96%)
Jul 21, 2026, 2:22 PM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 47.46 million as of July 21, 2026. Its market cap has decreased by -17.61% in one year.
Market Cap
47.46M
Enterprise Value
45.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
ChartMarket Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 47.46M, an increase of 41.74%. That is a compound annual growth rate of 8.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 47.46M | -20.70% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastwood Bio-Medical Canada | 66.82M |
| MedMira | 49.12M |
| BriaCell Therapeutics | 45.76M |
| Sernova Biotherapeutics | 43.43M |
| Microbix Biosystems | 41.33M |
| Sona Nanotech | 40.03M |
| Onco-Innovations | 38.72M |
| Telescope Innovations | 35.55M |